Fig. 2
From: The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia
Total MPN cases reported according to a JAK2 V617F mutation and b sex, and proportion in percentage according to c JAK2 V617F mutation and d sex
Fig. 2 | Experimental Hematology & Oncology